BidaskClub cut shares of Organovo Holdings, Inc. (NASDAQ:ONVO) from a sell rating to a strong sell rating in a report issued on Tuesday, July 25th.
Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Organovo Holdings from a sell rating to a hold rating in a report on Wednesday, April 12th. Jefferies Group LLC reiterated a buy rating and set a $4.00 price target (down previously from $4.50) on shares of Organovo Holdings in a report on Thursday, June 8th. Finally, Evercore ISI reiterated an outperform rating and set a $3.75 price target (down previously from $4.00) on shares of Organovo Holdings in a report on Friday, June 9th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $6.20.
Organovo Holdings (NASDAQ ONVO) traded down 4.55% during trading on Tuesday, hitting $2.10. 654,624 shares of the company’s stock traded hands. The company’s 50 day moving average is $2.57 and its 200-day moving average is $2.92. Organovo Holdings has a 12 month low of $2.09 and a 12 month high of $4.99.
Organovo Holdings (NASDAQ:ONVO) last announced its earnings results on Wednesday, June 7th. The company reported ($0.10) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.11) by $0.01. Organovo Holdings had a negative net margin of 908.91% and a negative return on equity of 63.92%. The business had revenue of $0.80 million during the quarter, compared to the consensus estimate of $0.76 million. The company’s quarterly revenue was up 700.0% compared to the same quarter last year. Equities analysts anticipate that Organovo Holdings will post ($0.39) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This article was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://stocknewstimes.com/2017/08/08/organovo-holdings-inc-onvo-lowered-to-strong-sell-at-bidaskclub-updated.html.
Large investors have recently modified their holdings of the company. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Organovo Holdings by 1.0% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 91,204 shares of the company’s stock valued at $240,000 after buying an additional 890 shares in the last quarter. State of Wisconsin Investment Board bought a new stake in shares of Organovo Holdings during the second quarter valued at about $196,000. Sigma Planning Corp boosted its stake in shares of Organovo Holdings by 13.7% in the second quarter. Sigma Planning Corp now owns 96,290 shares of the company’s stock valued at $253,000 after buying an additional 11,600 shares in the last quarter. Rhumbline Advisers boosted its stake in shares of Organovo Holdings by 4.4% in the second quarter. Rhumbline Advisers now owns 110,444 shares of the company’s stock valued at $290,000 after buying an additional 4,640 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its stake in shares of Organovo Holdings by 0.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 388,300 shares of the company’s stock valued at $1,022,000 after buying an additional 2,641 shares in the last quarter. Institutional investors own 22.77% of the company’s stock.
Organovo Holdings Company Profile
Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
